Experienced in Necrosis

Dr. Michael C. Stephens

Internal Medicine
2700 Se Stratus Ave, Suite 403, 
Mcminnville, OR 
Experienced in Necrosis
2700 Se Stratus Ave, Suite 403, 
Mcminnville, OR 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Stephens is a primary care provider, practicing in Internal Medicine in Mcminnville, Oregon. Dr. Stephens is rated as an Experienced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Crohn's Disease, Viral Gastroenteritis, Colitis, Kidney Transplant, and Endoscopy.

His clinical research consists of co-authoring 68 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Necrosis.

Specialties
Internal Medicine
Licenses
Internal Medicine in OR
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

2700 Se Stratus Ave, Suite 403, Mcminnville, OR 97128

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease: Pediatric Sub-study
A Phase I Study of Autologous Mesenchymal Stromal Cell Coated Fistula Plug in Patients With Fistulizing Crohn's Disease: Pediatric Sub-study
Enrollment Status: Completed
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Mesenchymal Stromal Cell-Coated Anal Fistula Plug
Study Phase: Phase 1
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Pragmatic Clinical Trial To Evaluate The Effectiveness Of Low Dose Oral Methotrexate In Patients With Pediatric Crohn's Disease Initiating Anti-TNF Therapy
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Pragmatic Clinical Trial To Evaluate The Effectiveness Of Low Dose Oral Methotrexate In Patients With Pediatric Crohn's Disease Initiating Anti-TNF Therapy
Enrollment Status: Completed
Publish Date: April 12, 2023
Intervention Type: Other, Drug
Study Drugs: Methotrexate, Ondansetron
Study Phase: Phase 3
View 3 Less Clinical Trials

68 Total Publications

Vulvovaginal involvement in Stevens-Johnson syndrome/toxic epidermal necrolysis: A retrospective review at a tertiary care center (2016-2024).
Vulvovaginal involvement in Stevens-Johnson syndrome/toxic epidermal necrolysis: A retrospective review at a tertiary care center (2016-2024).
Journal: Journal of the American Academy of Dermatology
Published: July 21, 2025
Similar Doctors
Advanced in Necrosis
Dr. Maziar Azadpour
Cardiology | Internal Medicine
Advanced in Necrosis
Dr. Maziar Azadpour
Cardiology | Internal Medicine
3303 Southwest Bond Avenue, Suite 9, 
Portland, OR 
 (31.7 miles away)
503-494-1775
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Maziar Azadpour is a Cardiologist and an Internal Medicine provider in Portland, Oregon. Dr. Azadpour is rated as an Advanced provider by MediFind in the treatment of Necrosis. His top areas of expertise are Arrhythmias, Sick Sinus Syndrome, Angina, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Azadpour is currently accepting new patients.

Advanced in Necrosis
Dr. Pamela R. Miner
Internal Medicine
Advanced in Necrosis
Dr. Pamela R. Miner
Internal Medicine

Housecall Providers PC

5100 S Macadam Ave, Suite 200, 
Portland, OR 
 (31.0 miles away)
971-202-5500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Pamela Miner is a primary care provider, practicing in Internal Medicine in Portland, Oregon. Dr. Miner is rated as an Advanced provider by MediFind in the treatment of Necrosis. Her top areas of expertise are Malnutrition, Short Bowel Syndrome, Small Bowel Bacterial Overgrowth, and Alcoholic Neuropathy. Dr. Miner is currently accepting new patients.

Advanced in Necrosis
Dr. Claire T. Kassakian
Nephrology | Internal Medicine
Advanced in Necrosis
Dr. Claire T. Kassakian
Nephrology | Internal Medicine
4224 Northeast Halsey Street, Suite 300, 
Portland, OR 
 (36.1 miles away)
503-235-5509
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Claire Kassakian is an Internal Medicine specialist and a Nephrologist in Portland, Oregon. Dr. Kassakian is rated as an Advanced provider by MediFind in the treatment of Necrosis. Her top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Nephrosclerosis. Dr. Kassakian is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stephens's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile